Determinants of substrate specificity for factor XIII

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 5, 1996, Pages 369-376

  McDonagh, Jan ^b   Fukue, Hidetake ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

factor XIIIa; factor XIIIa substrate complex; fibrin; fibronectin; 2 antiplasma

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13A; FIBRIN; FIBRONECTIN; MONOCLONAL ANTIBODY;

BLOOD CLOTTING; CONTROLLED STUDY; ENZYME SPECIFICITY; FIBRINOLYSIS; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030468786     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999034     Document Type: Review

References (47)

1. Lorand L: Activation of blood coagulation factor XIIIa. Ann NY Acad Sci 485:144-158, 1986.
2. Curtis CG, KL Brown, RB Credo, RA Domanik, A Gray, P Stenberg, L Lorand: Calcium-dependent unmasking of active-center cysteine during activation of fibrin stabilizing factor. Biochemistry 13:3774-3780, 1974.
3. Hornyak TJ, JA Shafer: Role of calcium ion in the generation of factor XIII activity. Biochemistry 30:6175-6182, 1991.
4. Schwartz ML, SV Pizzo, RL Hill, PA McKee: Human factor XIII from plasma and platelets. Molecular weights, subunit structure, proteolytic activation and cross-linking of fibrinogen and fibrin. J Biol Chem 248:1395-1407, 1973.
5. Grundmann U, E Amann, G Zettlmeissl, HA Küpper: Characterization of a cDNA coding for human factor XIIIa. Proc Natl Acad Sci USA 83:8024-8028, 1986.
6. Ichinose A, LE Hendrickson, K Fujikawa, EW Davie: Amino acid sequence of the a subunit of human factor XIII. Biochemistry 25:6900-6909, 1986.
7. Ichinose A, BA McMullen, K Fujikawa, EW Davie: Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. Biochemistry 25:4633-4638, 1986.
8. Grundmann U, C Nerlich, T Rein, G Zettlmeissl: Complete cDNA sequence encoding the B subunit of human factor XIII. Nucleic Acid Res 18:2817-2818, 1990.
9. Yee VC, LC Pedersen, I Le Trong, PD Bishop, RE Stenkamp, DC Teller: Three-dimensional structure of a transglutaminase: Human blood coagulation factor XIII. Proc Natl Acad Sci USA 91:7296-7300, 1994.
10. Pedersen LC, VC Yee, PD Bishop, I Le Trong, DC Teller, RE Stenkamp: Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Prot Sci 3:1131-1135, 1994.
11. McDonagh J: Structure and function of factor XIII. In: Colman RW, J Hirsh, VJ Marder, EW Salzman (Eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 2nd ed. Lippincott, Philadelphia, 1987, pp 289-301.
12. Shen LL, RP McDonagh Jr, J McDonagh, J Hermans Jr: Fibrin gel structure: Influence of calcium and covalent crosslinking on the elasticity. Biochem Biophys Res Commun 56:793-798, 1974.
13. Shen L, L Lorand: Contribution of fibrin stabilization to clot strength. J Clin Invest 71:1336-1341, 1983.
14. 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest 69:536-542, 1982.
15. Mosher DF: Crosslinking of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem 250:6614-6621, 1975.
16. Gross M, NK Whetzel, JE Folk: Amine binding sites in acyl intermediates of transglutaminases. Human blood plasma enzyme (activated coagulation factor XIII) and guinea pig liver enzyme. J Biol Chem 252:3752-3759, 1977.
17. Berliner LJ, YYW Shen: Physical evidence for an apolar binding site near the catalytic center of human α-thrombin. Biochemistry 16:4622-4626, 1977.
18. Gorman JJ, JE Folk: Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. J Biol Chem 259:9007-9010, 1984.
19. Achyuthan KE, A Mary, CS Greenberg: The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII. J Biol Chem 263:14296-14301, 1988.
20. Folk JE: Mechanism and basis for specificity of transglutaminase-catalyzed ε-(γ-glutamyl) lysine bond formation. Adv Enzymol 54:1-56, 1983.
21. Gorman JJ, JE Folk: Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. J Biol Chem 256:2712-2715, 1981.
22. Doolittle RF, KG Cassman, BA Cottrell, SJ Friezner: Amino acid sequence studies on the α-chain of human fibrinogen. Isolation and characterization of two linked α-chained cyanogen bromide fragments from fully crosslinked fibrin. Biochemistry 16:1715-1719, 1977.
23. 2-plasmin inhibitor. J Biol Chem 261:15591-15595, 1986.
24. McDonagh RP, J McDonagh, TE Peterson, HC Thorgersen, K Skorstengaard. L Sottrup-Jensen, S Magnusson: Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin. FEBS Lett 127:174-178, 1981.
25. Ribadeau Dumas B, G Brignon, F Grosclaude, J-C Mercier: Structure primaire de la caséine beta bovine. Séquence complète. Eur J Biochem 25:505-514, 1972.
26. Fukue H, K Anderson, P McPhedran, J Clyne, J McDonagh: A unique factor XIII inhibitor to a fibrin binding site on factor XIIIA. Blood 79:65-74, 1992.
27. Iwanaga S, K Suzuki, S Hashimoto: Bovine plasma cold-insoluble globulin: Gross structure and function. Ann NY Acad Sci 312:56-73, 1978.
28. Lynch GW, HW Slayter, BE Miller, J McDonagh: Characterization of thrombospondin as a substrate for factor XIII transglutaminase. J Biol Chem 262:1772-1778, 1987.
29. Mosesson MW, RA Umfleet: The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem 245:5728-5736, 1970.
30. Lorand L, T Urayama, JW De Kiewiet, HL Nossel: Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest 48:1054-1064, 1969.
31. Mosher DF, RB Johnson: Specificity of fibronectin-fibrin cross-linking. Ann NY Acad Sci 408:583-594, 1983.
32. Okada M, B Blombäck, MD Chang, B Horowitz: Fibronectin and fibrin gel structure. J Biol Chem 260:1811-1820, 1985.
33. McDonagh J, M Hada, M Kaminski: Plasma fibronectin: Structure and function. In: McDonagh J (ed): Plasma Fibronectin and Fibrin Formation. Marcel Dekker, New York 1985, pp 121-148.
34. Carr ME, DA Gabriel, J McDonagh: Influence of factor XIII and fibronectin on fiber size in thrombin-induced fibrin gels. J Lab Clin Med 110:747-752, 1987.
35. 2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor. Biochim Biophys Acta 661:280-286, 1981.
36. Greenberg CS, JJ Enghild, A Mary, JV Dobson, KE Achyuthan: Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen). Biochem J 256:1013-1019, 1988.
37. Hornyak TJ, JA Shafer: Interactions of factor XIII with fibrin as substrate and cofactor. Biochemistry 31:423-429, 1992.
38. Lewis SD, TJ Janus, L Lorand, JA Shafer: Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry 24:6772-6777, 1985.
39. Greenberg CS, CC Miraglia: The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation. Blood 66:466-469, 1985.
40. Folk JE, M Gross: Mechanism of action of guinea pig liver transglutaminase. VIII. Active site studies with "reporter" group-labeled halomethyl ketones. J Biol Chem 246:6683-6691, 1971.
41. Chung SI, JE Folk: Kinetic studies with transglutaminases. The human blood enzymes (activated coagulation factor XIII) and the guinea pig hair follicle enzyme. J Biol Chem 247:2798-2807, 1972.
42. Shen LL, J Hermans, J McDonagh, RP McDonagh Jr, M Carr: Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin gels. Thromb Res 6:255-265, 1975.
43. McDonagh RP Jr, J McDonagh, F Ducken: The influence of fibrin crosslinking on the kinetics of urokinase-induced clot lysis. Br J Haematol 21:323-332, 1971.
44. Duckert F: Documentation of the plasma factor XIII deficiency in man. Ann NY Acad Sci 202:190-199, 1972.
45. Gaffney PJ, AN Whitaker: Fibrin crosslinks and lysis rates. Thromb Res 14:85-94, 1979.
46. 2-plasmin inhibitor associated with severe hemorrhagic tendency. J Clin Invest 63:877-884, 1979.
47. Haverkate F: Lysis of crosslinked and non-crosslinked purified fibrin. Thromb Diath Haemorrh 34:584-585, 1975.